Search Results - "WAJGT, A"

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS by MILLER, D. H, SOON, D, KAPPOS, L, HUTCHINSON, M, HAVRDOVA, E, LUBLIN, F. D, GIOVANNONI, G, WAJGT, A, RUDICK, R, LYNN, F, PANZARA, M. A, SANDROCK, A. W, FERNANDO, K. T, MACMANUS, D. G, BARKER, G. J, YOUSRY, T. A, FISHER, E, O'CONNOR, P. W, PHILLIPS, J. T, POLMAN, C. H

“…In a 2-year, placebo-controlled trial (the Natalizumab Safety and Efficacy in Relapsing Remitting Multiple Sclerosis [AFFIRM] study), involving 942 patients…”
Get full text

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL by Hutchinson, M., Kappos, L., Calabresi, P. A., Confavreux, C., Giovannoni, G., Galetta, S. L., Havrdova, E., Lublin, F. D., Miller, D. H., O’Connor, P. W., Phillips, J. T., Polman, C. H., Radue, E.-W., Rudick, R. A., Stuart, W. H., Wajgt, A., Weinstock-Guttman, B., Wynn, D. R., Lynn, F., Panzara, M. A.

“…The AFFIRM and SENTINEL studies showed that natalizumab was effective both as monotherapy and in combination with interferon beta (IFNβ)-1a in patients with…”
Get full text

Natalizumab reduces visual loss in patients with relapsing multiple sclerosis by BALCER, L. J, GALETTA, S. L, O'CONNOR, P. W, PHILLIPS, J. T, POLMAN, C. H, RADUE, E.-W, RUDICK, R. A, STUART, W. H, WAJGT, A, WEINSTOCK-GUTTMAN, B, WYNN, D. R, LYNN, F, CALABRESI, P. A, PANZARA, M. A, CONFAVREUX, C, GIOVANNONI, G, HAVRDOVA, E, HUTCHINSON, M, KAPPOS, L, LUBLIN, F. D, MILLER, D. H

“…To examine the effects of natalizumab on low-contrast letter acuity as a prespecified tertiary endpoint in two randomized clinical trials and to evaluate the…”
Get full text

Infusion-related hypersensitivity reactions during natalizumab treatment by PHILLIPS, J. T, O'CONNOR, P. W, LYNN, F, PANZARA, M. A, SANDROCK, A. W, HAVRDOVA, E, HUTCHINSON, M, KAPPOS, L, MILLER, D. H, POLMAN, C. H, LUBLIN, F. D, GIOVANNONI, G, WAJGT, A

Get full text

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis by Polman, Chris H, O'Connor, Paul W, Havrdova, Eva, Hutchinson, Michael, Kappos, Ludwig, Miller, David H, Phillips, J. Theodore, Lublin, Fred D, Giovannoni, Gavin, Wajgt, Andrzej, Toal, Martin, Lynn, Frances, Panzara, Michael A, Sandrock, Alfred W

“…This placebo-controlled, randomized trial of patients with relapsing multiple sclerosis demonstrated benefits of natalizumab (an α 4 integrin antagonist) in…”
Get full text

CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies by Wajgt, A, Górny, M

“…Cerebrospinal fluid (CSF) from 40 multiple sclerosis (MS) patients was tested by solid-phase radioimmunoassay (RIA) for ability to bind 2 common structural…”
Get more information

Surface markers on lymphocytes of multiple sclerosis patients by Nowak, J, Wajgt, A

“…Peripheral blood lymphocytes of twenty-two multiple sclerosis (MS) patients and thirty-five healthy controls were examined for the presence of surface markers…”
Get full text

Therapeutic trials of multiple sclerosis and intrathecal IgG production by Wender, M, Tokarz, E, Michalowska, G, Wajgt, A

“…In our clinical trial we have compared the effect of high doses of prednisone, ACTH alone or ACTH and cyclophosphamide on plasma and CSF albumin and IgG…”
Get full text

Myelin-associated glycoprotein (MAG) in oligodendrogliomas. An immunohistochemical study by Szymaś, J, Wajgt, A

Get more information

Blood levels of selected hormones in patients with multiple sclerosis by Zych-Twardowska, E, Wajgt, A

“…Hormonal studies in patients with multiple sclerosis are rare and they often produce results which are difficult to interpret. These investigations, however,…”
Get more information

Cerebral lipids in a case with a clinically silent isolated plaque of the multiple sclerosis type by Wender, M, Adamczewska, Z, Wajgt, A

Get more information

Histoenzymology of experimental cyanide encephalopathy by Wender, M, Kozik, M, Wajgt, A

Get more information

Effect of immunosuppressive cladribine treatment on serum leucocytes system in two-year clinical trial in patients with chronic progressive multiple sclerosis by Janiec, K, Wajgt, A, Kondera-Anasz, Z

“…Multiple sclerosis is presumably cell-mediated autoimmune disorder with immune abnormalities as presence of activated T-cells and increase interleukin 2 (IL-2)…”
Get more information

Effect of immunosuppressive therapy on humoral immune response in multiple sclerosis by Wajgt, A, Górny, M, Szczechowski, L, Grzybowski, G, Ochudło, S

“…The purpose of this study was to evaluate the effect of various therapeutic regimens on: 1) intrathecal IgG synthesis on the basis of IgG Index value, 2)…”
Get more information

Activity of sRNA-amino acyl synthetases in experimental cyanide encephalopathy by Wender, M, Zgorzalewicz, B, Wajgt, A

Get more information

Myelin associated glycoprotein (MAG) in Wallerian degeneration of the optic nerve by Wender, M, Wajgt, A, Michałowska, G, Tokarz, E

“…The content of myelin associated glycoprotein (MAG) was studied in the rabbit optic nerves undergoing Wallerian degeneration after ophthalmectomy . MAG was…”
Get more information

Cerebral lipids in experimental cyanide encephalopathy by Wender, M, Adamczewska, Z, Wajgt, A

Get more information

Cerebral proteins in experimental allergic encephalomyelitis by Wender, M, Piechowski, A, Wajgt, A

Get more information

Comparative assessment of treatment efficacy with lamotrigine (Lamictal) together with valproate and/or carbamazepine in patients with refractory epilepsy by Wierzba, W, Wajgt, A

“…For the study 17 patients aged 26-55 years were qualified after ineffective treatment with carbamazepine and/or valproate for simple partial, complex partial…”
Get more information

Late changes in the enzymatic activity of the neuroglia as a sequel to acute hydrogen cyanide poisoning by Wender, M, Kozik, M, Wajgt, A

Get more information